Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,430
-400 (-3.12%)
Dec 5, 2025, 3:30 PM KST
93.31%
Market Cap 140.36B
Revenue (ttm) 620.44B
Net Income (ttm) 67.54B
Shares Out 11.29M
EPS (ttm) 5,327.40
PE Ratio 2.42
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 129,726
Average Volume 747,969
Open 12,600
Previous Close 12,830
Day's Range 12,070 - 12,980
52-Week Range 5,470 - 16,370
Beta 0.55
RSI 48.28
Earnings Date Nov 6, 2025

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 72
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.